Back to results
US 2004/0082623 A1Published application
Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
OwnerStephane Rochhi, Johan Auwerx +1inventors
InventorsStephane Rochhi, Johan Auwerx, Joseph Vamecq
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating or preventing a PPAR-γ mediated disease or condition comprising administration of a therapeutically effective amount of FMOC-L-Leucine or derivatives thereof, of the formula I. Said method is particularly useful for treating or preventing anorexia, hyperlypidemia, insulin resistance, inflammatory diseases, cancer and sking disorders. 1
Claims19
A method for treating or preventing a PPAR-γ mediated disease or condition comprising administration of a therapeutically effective amount of a compound having the formula I:
- 8
- wherein R1 is selected from a linear or branched alkyl, alkenyl and alkynyl group comprising from 1 to 6 carbon atoms,
- X is a chain comprising from 1 to 6 carbon atoms which may comprise one to four heteroatoms,
- R2 is a condensed polycyclic group comprising at least two cycles.
1 more element
Dependencies are inferred from the claim text.